ED significantly ameliorated by irbesartan
| Medienart: |
Artikel |
|---|
| Erscheinungsjahr: |
2008 |
|---|---|
| Erschienen: |
2008 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:1662 |
|---|---|
| Enthalten in: |
Inpharma weekly - 1662(2008), 1 vom: Nov., Seite 18-18 |
| Sprache: |
Englisch |
|---|
| Links: |
Volltext [lizenzpflichtig] |
|---|
| BKL: | |
|---|---|
| Themen: |
Erectile Dysfunction |
| Anmerkungen: |
© Adis International Ltd 2008 |
|---|
| doi: |
10.2165/00128413-200816620-00037 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
OLC209483784X |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | OLC209483784X | ||
| 003 | DE-627 | ||
| 005 | 20230331175921.0 | ||
| 007 | tu | ||
| 008 | 230331s2008 xx ||||| 00| ||eng c | ||
| 024 | 7 | |a 10.2165/00128413-200816620-00037 |2 doi | |
| 035 | |a (DE-627)OLC209483784X | ||
| 035 | |a (DE-He213)00128413-200816620-00037-p | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 082 | 0 | 4 | |a 610 |q VZ |
| 084 | |a 15,3 |2 ssgn | ||
| 084 | |a PHARM |q DE-84 |2 fid | ||
| 084 | |a 44.40 |2 bkl | ||
| 245 | 1 | 0 | |a ED significantly ameliorated by irbesartan |
| 264 | 1 | |c 2008 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 500 | |a © Adis International Ltd 2008 | ||
| 650 | 4 | |a Hypertension | |
| 650 | 4 | |a Metabolic Syndrome | |
| 650 | 4 | |a Erectile Dysfunction | |
| 650 | 4 | |a Hydrochlorothiazide | |
| 650 | 4 | |a Impotence | |
| 773 | 0 | 8 | |i Enthalten in |t Inpharma weekly |d Springer International Publishing, 1990 |g 1662(2008), 1 vom: Nov., Seite 18-18 |w (DE-627)219596085 |w (DE-600)1345808-5 |w (DE-576)435516728 |x 1173-8324 |7 nnns |
| 773 | 1 | 8 | |g volume:1662 |g year:2008 |g number:1 |g month:11 |g pages:18-18 |
| 856 | 4 | 1 | |u https://doi.org/10.2165/00128413-200816620-00037 |z lizenzpflichtig |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a SYSFLAG_A | ||
| 912 | |a GBV_OLC | ||
| 912 | |a FID-PHARM | ||
| 912 | |a SSG-OLC-PHA | ||
| 912 | |a SSG-OPC-PHA | ||
| 912 | |a GBV_ILN_20 | ||
| 936 | b | k | |a 44.40 |q VZ |
| 951 | |a AR | ||
| 952 | |d 1662 |j 2008 |e 1 |c 11 |h 18-18 | ||